PharMerica loses $5.5 million in 4Q - Tampa Bay Business Journal:

lebexab.wordpress.com
million, or 18 cents per share, in the fourt quarter of 2008, largely due to a one-time charge of $14.i8 million resulting from a higher-than-anticipated loss of PharMerica said that without the charge it wouldr have earned 26 centsper share. The numbefr of licensed beds operated by PharMerica customers fellnearly 4.4 percent from the fourth quarter 2007 to the fourthg quarter 2008, according to a media release. As of Dec. 31 PharMericz customers operated 322,376 beds. The company reported fourth-quarter revenud of $479.7 million, compared with $492.
2 million a year PharMerica was created in Augusyt 2007 through the combination of the institutional and hospita l pharmacy business units of and PharMeric a has a major service centet at the Corporex Office Parkin Tampa. A consensusa of Thomson Reuters analysts had predictede earnings of 21 cents per sharr on revenueof $489.5 million. The companuy reported net incomeof $2.8 million, or 9 centz per share, in the fourth quarter of 2007. Despitwe the writedown that forced the company intoa fourth-quarter PharMerica CEO Gregory S.
Weishar said in a released that officialsare “extremely pleased with the progress” of the which just completed its first full calendar year of “Looking forward to 2009, we enter the year a much strongere company,” Weishar said in the release. “With the merger behindc us, we can now focus our energies aroune growing ourclient base, improving clienty retention and acquisitions. We are confident we can post solid growth in 2009 and For thefull year, PharMerica reportedc net income of $5 million, or 17 centxs per share, compared with a loss of $13.4e million, or $1.13 per in 2007. Revenue increased to $1.9 from $1.2 billion. Louisville, Ky.
-based PharMerica (NYSE: PMC) said its pharmaciese dispensed a total of 10 million prescriptions during the fourth quarterand 40.3 million for the full The company operates more than 100 institutionalk pharmacies in more than 40 states. In the release, PharMericaz officials projected full-year 2009 net income in the rangof $1.11 to $1.18 per sharr on revenue of $1.96 billion to $1.97 billion.